First Time Loading...
W

Wanbangde Pharmaceutical Holding Group Co Ltd
SZSE:002082

Watchlist Manager
Wanbangde Pharmaceutical Holding Group Co Ltd
SZSE:002082
Watchlist
Price: 4.87 CNY 0.41% Market Closed
Updated: Jun 2, 2024

Wanbangde Pharmaceutical Holding Group Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Wanbangde Pharmaceutical Holding Group Co Ltd
Other Long-Term Assets Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
W
Wanbangde Pharmaceutical Holding Group Co Ltd
SZSE:002082
Other Long-Term Assets
¥264.7m
CAGR 3-Years
37%
CAGR 5-Years
14%
CAGR 10-Years
54%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Other Long-Term Assets
¥805.9m
CAGR 3-Years
9%
CAGR 5-Years
-2%
CAGR 10-Years
6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Long-Term Assets
¥217.4m
CAGR 3-Years
-19%
CAGR 5-Years
15%
CAGR 10-Years
29%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Long-Term Assets
¥705.6m
CAGR 3-Years
41%
CAGR 5-Years
26%
CAGR 10-Years
35%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Long-Term Assets
¥420.8m
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
10%

See Also

What is Wanbangde Pharmaceutical Holding Group Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
264.7m CNY

Based on the financial report for Mar 31, 2024, Wanbangde Pharmaceutical Holding Group Co Ltd's Other Long-Term Assets amounts to 264.7m CNY.

What is Wanbangde Pharmaceutical Holding Group Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
54%

Over the last year, the Other Long-Term Assets growth was 71%. The average annual Other Long-Term Assets growth rates for Wanbangde Pharmaceutical Holding Group Co Ltd have been 37% over the past three years , 14% over the past five years , and 54% over the past ten years .